LONDON, UK AND PLANO, TX, August 2, 2019. Belluscura PLC announces the successful close of its latest fundraising round. Raising $2.7m, the private placing was priced at US$0.185 (15p) per share, giving Belluscura a post-money valuation of approximately US$9.0m.
Beginning with an over-subscribed UK crowdfunding campaign on CrowdCube earlier this year, 12 existing shareholders and 325 new shareholders invested in Belluscura during the latest raise. The funds will be used by Belluscura to complete regulatory clearance and launch its innovative X-PLOR portable oxygen concentrator.
Commenting on the Private Placement, Bob Rauker, CEO of Belluscura, said: “We are very pleased to announce the successful close of this fundraising round. We are diligently working toward the commercial launch of the X-PLOR along with filling the product pipeline with additional novel oxygen-enrichment products.”
Background to Belluscura
Belluscura was established in the UK in December 2015. The company’s mission is enriching lives through innovation.
Contact: Investor Relations